According to Adaptive Biotechnologies 's latest financial reports the company's current EPS (TTM) is -$1.33. In 2022 the company made an earnings per share (EPS) of -$1.41 an increase over its 2021 EPS that were of -$1.47.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.33 | -5.67% |
2022 | -$1.41 | -4.08% |
2021 | -$1.47 | 32.43% |
2020 | -$1.11 | -33.3% |
2019 | -$1.66 | 280.18% |
2018 | -$0.44 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
HCA Healthcare HCA | $20.75 | -1,660.33% | ๐บ๐ธ USA |
Premier PINC | $1.54 | -215.79% | ๐บ๐ธ USA |
Community Health Systems
CYH | $1.83 | -237.59% | ๐บ๐ธ USA |
Select Medical Holdings SEM | $1.60 | -220.30% | ๐บ๐ธ USA |